Hepatitis B Surface Antigen (HBsAg) with reflex to PCR for REACTIVE
- Lab Name
- Hepatitis B surf Ag w/RFLX PCR
- Lab Code
- Epic Ordering
- Hepatitis B Surface Antigen
The Qualitative detection of Hepatitis B virus Surface Antigen (HBSAg) in human sera using the FDA approved ARCHITECT HBsAg test one-step chemiluminescent microparticle immunoassay (CMIA).
Sample, assay diluent, and Hepatitis Surface antibody (anti-HBs) coated paramagnetic microparticles are combined. HBsAg present in the sample binds to the anti-HBs coated microparticles and to the anti-HBs acridinium-labeled conjugate. Then pre-trigger and trigger solutions are added to the reaction mixture. The resulting chemiluminescent reaction is measured as relative light units (RLUs).
The presence or absence of HBSAg in the sample is determined by comparing the chemiluminescent signal in the reaction to the cutoff signal determined from an ARCHITECT HBsAg calibration. Specimens with signal to cutoff (S/CO) values ≥ 1.00 are considered reactive for HBSAg. Specimens with S/CO values < 1.00 are considered nonreactive.
Reactive HBSAg are confirmed by neutralization assay at no charge (see part II). Confirmed positives are reflexed to Hepatitis B PCR Quantitative Hepatitis B PCR Quantitative [HBVQNT] for final confirmation with an additional charge.
The Abbott ARCHITECT HBsAg Qualitative Confirmatory CMIA consists of two single tests, a neutralized and a non-neutralized or baseline assay, that are both one-step pre-treatment immunoassays:
Test 1 (neutralized)
- Sample and Pre-Treatment reagent are combined in one reaction vessel (RV). When HBsAg is present in the sample, it is neutralized by the antibody (anti-HBs) in the Pre-Treatment Reagent.
Test 2 (non-neutralized)
- Sample and diluent are combined in a second RV to serve as a baseline to calculate the % neutralization. Anti-HBs coated paramagnetic microparticles, and anti-HBs acridinium-labeled conjugate are added to each test RV. Any non-neutralized HBsAg present in the sample binds to the anti-HBs coated microparticles and to the anti-HBs acridinium-labeled conjugate. The neutralized HBsAg is blocked from forming a sandwich with acridinium-labeled anti-HBs conjugate and anti-HBs coated microparticles. Then pre-trigger and trigger solutions are added to the reaction mixtures. The resulting chemiluminescent reactions are measured as RLUs.
The presence or absence of HBSAg in the sample is determined by comparing the chemiluminescent signal in the reaction to the cutoff signal determined from an ARCHITECT HBsAg confirmatory calibration. Specimens with a ≥ 50% neutralization between the sample pretreated with Pre-Treatmeant reagent (test 1) and the sample pretreated with diluent (test 2) are confirmed positive for HBSAg.
For HBSAg testing without reflex testing, see Hepatitis B Surface Antigen without PCR reflex for REACTIVE [HBSAGX].
For Batteries containing HBSAg see:
Hepatitis B Battery [HBB], Quantitative detection of Hepatitis B virus Surface IgG antibody (HBSAb), Qualitative detection of Hepatitis B virus Surface Antigen (HBSAg) and Qualitative detection of Hepatitis B virus Core IgG and IgM antibodies (HBCAb)
Hepatitis B Surface Antigen & Antibody (HBsAg, HBsAb) [HBSS], Quantitative detection of Hepatitis B virus Surface IgG antibody (HBSAb) and Qualitative detection of Hepatitis B virus Surface Antigen (HBSAg)
- HBsAg, Hepatitis B antigen
Code Name HBAG Hepatitis B surf Ag w/RFLX PCR
- Reference Range
- See individual components
Ordering & Collection
- Specimen Type
All Locations:2 tubes required if reflex testing is ordered
Preferred: 5 mL blood in GOLD SST tube plus 5 mL blood in PEARL PPT tube
Also acceptable: 5 mL blood in ORANGE RST or RED TOP tube plus a 5 mL PEARL PPT tube for reflexive testing.
Note: If no PEARL PPT is received, any reflexive molecular testing can be done on GOLD SST, LAVENDER or RED TOP Tube that has not been on automated lines.
- Handling Instructions
requested: 1.0 mL serum
minimum: 0.5mL serum
GOLD SST tube: Specimens may be stored on or off the clot, red blood cells, or separator gel for up to 3 days at room temperature (15-30°C) or up to 7 days at 2-8°C. If testing will be delayed more than 3 days for specimens stored at room temperature or more than 7 days for specimens stored at 2-8°C, remove serum from the clot, red blood cells, or separator gel and store at -20°C or colder. Avoid more than three freeze/thaw cycles.
PEARL PPT tube: centrifuge within 6 hours of collection and freeze spun PEARL PPT tube at -20°C. Route frozen PEARL tubes to UW SPS -20°C freezer rack 80. [ok to freeze spun pearl top tubes on gel.]
Unacceptable samples: Cord blood, neonatal specimens, cadaver specimens, heat-inactivated specimens, or body fluids such as saliva, urine, amniotic fluid, or pleural fluid. Specimens with obvious microbial contamination or are grossly hemolyzed.
- Transport Temperature
- LIS Dept Code
- Clinical Virology (CVIR)
- Performing Location(s)
- Available STAT?
Billing & Coding
- CPT codes